Clinical verification of the relationship between smoking and the immune microenvironment of breast cancer
Authors:
- Koji TakadaKTKoji Takada
- Shinichiro KashiwagiShinichiro Kashiwagi
- Yuka AsanoYAYuka Asano
- Wataru GotoWGWataru Goto
- Katsuyuki TakahashiKTKatsuyuki Takahashi
- Hisakazu FujitaHFHisakazu Fujita
- Tsutomu TakashimaTTTsutomu Takashima
- Shuhei TomitaSTShuhei Tomita
- Kosei HirakawaKHKosei Hirakawa
- Masaichi OhiraMOMasaichi Ohira
Open Access
- 7 January 2019
- journal article
- research article
- Published by Springer Nature in Journal of Translational Medicine
- Vol. 17 (1) , 13
Abstract
The immune tumor microenvironment (iTME) is thought to affect the response to chemotherapy, and tumor-infiltrating lymphocytes (TILs) are often used as an indicator to evaluate the iTME. Smoking is involved in carcinogenesis, the relationship between smoking and the iTME of lung cancer has been reported. We hypothesized that smoking would affect the iTME of breast cancer and aimed to examine this relationship based on the amount of pre-diagnosis smoking and the subsequent effects on treatment response and prognosis. This retrospective study evaluated data from 149 patients who underwent preoperative chemotherapy for triple-negative or HER2-enriched breast cancer. TILs were assessed in biopsy specimens at diagnosis. The data of all patients were used to calculate each patient’s smoking amount based on pack-years. Relative to the low smoking group, the high smoking group had a significant greater TILs density (p = 0.043) and a significantly better pathological complete response (pCR) rate (p = 0.042). However, there was no significant difference according to smoking amount in disease-free survival (p = 0.114) or overall survival (p = 0.347). Smoking may influence the iTME, with an activated iTME being associated with pCR rate. Therefore, controlled activation of the microenvironment in this setting may help improve patients’ prognosis.Keywords
Funding Information
- Japan Society for the Promotion of Science (25461992, 26461957, 17K10559)
This publication has 39 references indexed in Scilit:
- Variation in the Incidence and Magnitude of Tumor-Infiltrating Lymphocytes in Breast Cancer SubtypesJAMA Oncology, 2016
- A case–control analysis of smoking and breast cancer in African American women: findings from the AMBER ConsortiumCarcinogenesis, 2016
- RAS/MAPK Activation Is Associated with Reduced Tumor-Infiltrating Lymphocytes in Triple-Negative Breast Cancer: Therapeutic Cooperation Between MEK and PD-1/PD-L1 Immune Checkpoint InhibitorsClinical Cancer Research, 2016
- Partial mastectomy using manual blunt dissection (MBD) in early breast cancerBMC Surgery, 2015
- Active smoking and the risk of estrogen receptor‐positive and triple‐negative breast cancer among women ages 20 to 44 yearsCancer, 2014
- Cancer Immunotherapy2013
- Lifetime Cigarette Smoking and Breast Cancer Prognosis in the After Breast Cancer Pooling ProjectJNCI: Journal of the National Cancer Institute, 2013
- Active and passive cigarette smoking and breast cancer risk: Results from the EPIC cohortInternational Journal of Cancer, 2013
- New response evaluation criteria in solid tumours: Revised RECIST guideline (version 1.1)European Journal of Cancer, 2009
- Preoperative chemotherapy for women with operable breast cancerCochrane Database of Systematic Reviews, 2007